ADX10059 a Negative Allosteric Modulator of the Metabotropic Glutamate 5 Receptor (mGlur5) Effectively Controls Chorea and Dystonia in a Primate Model of Levodopa Induced Dyskinesia

被引：0

|

作者：

Keywood, Charlotte G.

Bezard, Erwan

Girard, Francoise

Mutel, Vincent

机构：

来源：

NEUROLOGY | 2010年 / 74卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：A393 / A393

页数：1

相关论文

共 50 条

[1] Efficacy and Tolerability of ADX10059, a Negative Allosteric Modulator of mGluR5, On Gastro-Esophageal Reflux: A pH-Impedance Study in Healthy Subjects
Zerbib, Frank
Keywood, Charlotte
GASTROENTEROLOGY, 2009, 136 (05) : A434 - A435
[2] Clinical Efficacy and Tolerability of Monotherapy With ADX10059, a mGluR5 Negative Allosteric Modulator, for Symptom Control in Patients With Gastro-Esophageal Reflux Disease (GERD)
Zerbib, Frank
Galmiche, Jean-Paul
Mion, Francois
Keywood, Charlotte
GASTROENTEROLOGY, 2010, 138 (05) : S648 - S648
[3] Modulation of metabotropic glutamate subtype 5 receptor (mGluR5) in dyskinesia
Brownell, Anna-Liisa
Jokivarsi, Kimmo
Isacson, Ole
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[4] Efficacy and Tolerability of ADX10059, a mGluR5 Negative Allosteric Modulator, as Add on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux Disease (GERD)
Castell, Donald O.
Zerbib, Frank
des Varannes, Stanislas Bruley
Galmiche, Jean Paul
Vaezi, Michael F.
Keywood, Charlotte
GASTROENTEROLOGY, 2011, 140 (05) : S577 - S577
[5] ADX10059, a negative allosteric modulator of mGluR5, demonstrates proof of concept for a role in the management of migraine, in a placebo controlled phase2a study.
Keywood, C.
Wakefield, Mark
NEUROPHARMACOLOGY, 2008, 55 (04) : 605 - 605
[6] Efficacy, tolerability and pharmacokinetics of a modified release formulation of ADX10059, a negative allosteric modulator of metabotropic glutamate receptor 5: an esophageal pH-impedance study in healthy subjects
Zerbib, F.
Keywood, C.
Strabach, G.
NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (08): : 859 - E231
[7] Functional interaction of metabotropic glutamate receptor 5 (mGluR5) and NMDA-receptor by an mGluR5 positive allosteric modulator in-vitro and in-vivo
Rosenbrock, H.
Kramer, G.
Hobson, S.
Grundl, M.
Grauert, M.
NEUROPHARMACOLOGY, 2008, 55 (04) : 622 - 622
[8] The mGluR5 Negative Allosteric Modulator Dipraglurant Reduces Dyskinesia in the MPTP Macaque Model
Bezard, Erwan
Pioli, Elsa Y.
Li, Qin
Girard, Francoise
Mutel, Vincent
Keywood, Charlotte
Tison, Francois
Rascol, Olivier
Poli, Sonia M.
MOVEMENT DISORDERS, 2014, 29 (08) : 1074 - 1079
[9] A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease
Keywood, C.
Wakefield, M.
Tack, J.
GUT, 2009, 58 (09) : 1192 - 1199
[10] Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5)
Williams, DL
Lindsley, CW
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (09) : 825 - 846

← 1 2 3 4 5 →